Skip to main content
Clinical Trials/NCT05202210
NCT05202210
Recruiting
N/A

Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome and to Identify Predictive Factors of Disease Progression

University Hospital, Toulouse1 site in 1 country100 target enrollmentJanuary 26, 2022

Overview

Phase
N/A
Intervention
blood and urine sampling
Conditions
Noonan Syndrome
Sponsor
University Hospital, Toulouse
Enrollment
100
Locations
1
Primary Endpoint
Constitution of a biological collection from patients with Noonan or related syndromes.
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

The present study will establish a collection of biological samples from Noonan patients to be used for research purposes only, with due respect for confidentiality.

Detailed Description

Noonan syndrome is a rare autosomal dominant genetic disorder characterized by a combination of typical facial features, heart defects, short stature, skeletal abnormalities, mild developmental delay and a predisposition to myeloproliferative disorders. This syndrome is caused by germline mutations in genes encoding components or regulators of the Rat Sarcoma (RAS) / extracellular signal-regulated kinase (ERK) signaling pathway, which is essential for cell cycle differentiation, growth, and senescence. Patients with Noonan syndrome or related diseases are followed at the children's hospital, Toulouse University Hospital. During regular check-up visits, an extra sample of blood and urine will be collected and stored for research utilisation with the patient's consent. The ultimate objective of this collection is to provide available biological resources to facilitate the development of subsequent studies aimed at better characterizing the multisystemic disorders in Noonan syndrome, to understand the pathophysiology of the disease, and to identify biological factors that predict the severity and progression of the disease. The possibility of having systematically collected biological resources will make it possible to answer certain questions more quickly depending on the progress of research.

Registry
clinicaltrials.gov
Start Date
January 26, 2022
End Date
January 26, 2032
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children aged at least 3 years old or adult with Noonan syndrome
  • Patients affiliated to or beneficiaries of a social security scheme
  • Patients able to receive information on the progress of the study and understand the information form to participate in the study. That implies to master the French language and not to be subject to a restriction of rights by the judicial authorities
  • Patients or legal representative who have given their consent to participate in the study (expression of no objection)

Exclusion Criteria

  • Patients subject to a legal protection measure (guardianship, curators, or safeguard of justice)
  • Pregnant or breastfeeding women

Arms & Interventions

patients with Noonan syndrome

extra sample of blood and urine will be collected and stored for research utilisation

Intervention: blood and urine sampling

Outcomes

Primary Outcomes

Constitution of a biological collection from patients with Noonan or related syndromes.

Time Frame: inclusion

extra sample of blood and urine will be collected

Study Sites (1)

Loading locations...

Similar Trials